Rh. Moseley et al., MECHANISMS FOR THE HEPATIC-UPTAKE AND BILIARY-EXCRETION OF TRIBUTYLMETHYLAMMONIUM - STUDIES WITH RAT-LIVER PLASMA-MEMBRANE VESICLES, The Journal of pharmacology and experimental therapeutics, 276(2), 1996, pp. 561-567
Hepatic organic cation transport in vitro, using tetraethylammonium (T
EA) as a substrate, consists of at least two steps: sinusoidal uptake
is stimulated by an inside-negative membrane potential and canalicular
membrane transport is mediated by organic cation:H+ exchange (Moseley
et al., 1992b). In vivo, however, TEA is poorly excreted into bile. I
n contrast, larger, more hydrophobic organic cations, such as tributyl
methylammonium (TBuMA), undergo significant hepatobiliary excretion. T
o better characterize hepatic organic cation transport, TBuMA transpor
t was examined in rat canalicular liver plasma membrane (cLPM) and bas
olateral liver plasma membrane (blLPM) vesicles. In cLPM vesicles, und
er voltage-clamped conditions, an outwardly directed H+ gradient stimu
lated [H-3]TBuMA uptake consistent with electroneutral TBuMA:H+ exchan
ge; H+-dependent [H-3]TBuMA uptake was not the result of a H+ diffusio
n potential. In the absence of a H+ gradient, intravesicular TBuMA tra
ns-stimulated [H-3]TBuMA uptake. Substrates for renal and hepatic orga
nic cation:H+ exchange cis-inhibited H+-dependent [H-3]TBuMA uptake. N
o ATP-dependent [H-3]TBuMA uptake was detected in cLPM vesicles, and t
he P-glycoprotein substrate, daunomycin, did not cis-inhibit H+-depend
ent [H-3]TBuMA uptake. Carrier-mediated [H-3]TBuMA uptake exhibited sa
turability (K-m of 0.5 mM and V-max of 0.5 nmol/mg prot/5 s). In blLPM
vesicles, in contrast, a valinomycin-induced intravesicular-negative
K+ diffusion potential stimulated [H-3]TBuMA uptake. These findings su
ggest that hepatic transport of TBuMA is similar to TEA but fundamenta
lly different from that of P-glycoprotein substrates, indicating the i
nvolvement of at least two separate processes for the hepatobiliary ex
cretion of organic cationic drugs.